This inventor holds 3 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Glaxosmithkline Intellectual Property Development Limited. Active years: 2020-2022.
Company Filing History:
Years Active: 2020-2022
Title: The Innovations of Nicolas Eric Faucher
Introduction
Nicolas Eric Faucher is a notable inventor based in Les Ulis, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of kinase inhibitors. With a total of 3 patents to his name, Faucher continues to push the boundaries of innovation in his industry.
Latest Patents
One of his latest patents includes the development of heterocyclic amides as kinase inhibitors. This patent discloses compounds that have the potential to be used in various therapeutic applications. The innovative nature of his work highlights the importance of research in advancing medical science.
Career Highlights
Faucher is currently employed at GlaxoSmithKline Intellectual Property Development Limited, where he applies his expertise in drug development and patenting. His work at this prominent company allows him to collaborate with other leading scientists and contribute to groundbreaking research.
Collaborations
Throughout his career, Faucher has worked alongside talented individuals such as Niall Andrew Anderson and Deepak Bandyopadhyay. These collaborations have enriched his research and fostered an environment of innovation.
Conclusion
Nicolas Eric Faucher's contributions to the field of pharmaceuticals through his patents and collaborations demonstrate his commitment to advancing medical science. His work continues to inspire future innovations in the industry.